For the quarter ending 2025-12-31, BENFW had $2,965K increase in cash & cash equivalents over the period. -$9,373K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Investment income (loss), net | -25,373 | -3,162 | -12,776 | -6,500 |
| Loss on extinguishment of debt | - | - | - | 0 |
| Net income (loss) | 5,940 | -17,907 | -92,648 | -803 |
| Depreciation and amortization | 141 | 143 | 242 | 1,695 |
| Net amortization of debt premium and discount (related party of 615 and 202) | 433 | 90 | 92 | 296 |
| Loss on impairment of goodwill | 0 | 0 | 0 | 3,692 |
| Gain (loss) on financial instruments, net (related party of and (546)) | 43,845 | 211 | -45 | -2,242 |
| Non cash interest expense (related party of 9,088 and 7,124) | 5,280 | 4,600 | 2,764 | 12,214 |
| Non cash interest income | 10 | 117 | 139 | 494 |
| Non cash share-based compensation | 367 | 462 | 461 | 5,649 |
| Provision for credit losses | 0 | 0 | 0 | 1,000 |
| Accrual (release) of loss contingency related to arbitration award | 0 | 0 | 62,831 | 54,973 |
| Provision for deferred taxes | 0 | 43 | - | 80 |
| (gain) loss on liability resolution | 1,996 | 0 | - | 23,462 |
| Changes in other assets | -635 | 2,056 | -1,101 | 32,784 |
| Changes in accounts payable and accrued expenses | -1,691 | -2,737 | 1,639 | 41,445 |
| Changes in other liabilities and deferred revenue | - | 0 | 0 | 0 |
| Net cash used in operating activities | -9,373 | -14,528 | -10,836 | -37,703 |
| Return of investments in alternative assets held by customer exalt trusts | 3,538 | 4,069 | 3,711 | 30,368 |
| Proceeds from disposition of alternative assets held by customer exalt trusts | 13,006 | 13,115 | 24,059 | - |
| Purchase of investments in alternative assets held by customer exalt trusts | 121 | 814 | 1,219 | 1,219 |
| Purchase of premises and equipment | 0 | 0 | 96 | 1,099 |
| Proceeds from sale of put options by ben | - | - | - | 0 |
| Proceeds from sale of public equity securities held by customer exalt trusts | - | - | - | 55 |
| Net cash provided by investing activities | 16,423 | 16,370 | 26,455 | 28,105 |
| Proceeds from related party debt financings | 0 | 0 | 850 | 1,675 |
| Payments on related party debt financings | 4,085 | 4,552 | 10,474 | 4,675 |
| Proceeds from issuance of convertible debt | 0 | 0 | - | 3,575 |
| Payments on convertible debt | 0 | - | - | 4,000 |
| Redemption of preferred series b subclass 2 unit accounts-Preferred Series BSubclass2 | - | - | - | 0 |
| Proceeds received from issuance of class a common shares under equity purchase agreement | 0 | 0 | 271 | 7,859 |
| Payment of deferred financing costs for debt | - | - | - | 0 |
| Payment of deferred financing costs for equity | 0 | 0 | 0 | 2,140 |
| Distribution to noncontrolling interest | - | - | - | 0 |
| Proceeds from sale of class a common shares | 0 | 0 | - | 673 |
| Payment of employee income taxes on restricted equity units | - | - | - | 0 |
| Proceeds from de-spac merger | - | - | - | 0 |
| Payment for prepaid forward purchase agreement | - | - | - | 0 |
| Net cash (used in) provided by financing activities | -4,085 | -4,552 | -9,353 | 2,967 |
| Net increase (decrease) in cash and cash equivalents | 2,965 | -2,710 | 6,266 | -6,631 |
| Cash and cash equivalents at beginning of period | 4,902 | 7,612 | 1,346 | 7,977 |
| Cash and cash equivalents at end of period | 7,867 | 4,902 | 7,612 | 1,346 |
Beneficient (BENFW)
Beneficient (BENFW)